We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Tokai Hopes To Move $97M Suit Over IPO To Mass. Fed. Court

Law360, New York (December 20, 2016, 6:30 PM EST) -- Tokai Pharmaceuticals Inc. Monday sought to move a putative class action by investors claiming it withheld important drug testing information prior to its $97 million initial public offering to a Massachusetts federal court Monday.

The suit, filed by investor Hao Wu in Massachusetts state court two weeks ago, claims the company failed to properly test the prostate cancer drug it was developing and its IPO underwriters did not warn investors of this, causing them to be blindsided when the drug failed and the stock plunged....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.